Dr Mark Young
(e/fe)
Rhaglenni Arwain, Ôl-raddedig a Addysgir
- Ar gael fel goruchwyliwr ôl-raddedig
Trosolwyg
Trosolwg ymchwil
Fy mhrif ddiddordebau yw deall sut mae strwythur 3D derbynyddion P2X mamalaidd yn ymwneud â'u swyddogaeth a signalau celloedd mewn poen cronig a llid.
Mae derbynyddion P2X yn sianeli ïonau arwyneb celloedd sy'n cael eu gweithredu gan ATP allgellog. Mae actifadu yn arwain at gyfres o ddigwyddiadau signalau i lawr yr afon sydd â chanlyniadau pwysig ar gyfer trosglwyddo nerfau, teimlad poen, llid a rheolaeth tôn cyhyrau llyfn. Am y rhesymau hyn, mae'n ddigon posibl y bydd gan gyffuriau sy'n targedu derbynyddion P2X gamau analgesig neu gwrthlidiol. Byddai'r broses o ddarganfod cyffuriau yn cael ei chyflymu pe bai strwythurau 3D cydraniad uchel derbynyddion P2X dynol ar gael, gan hwyluso dylunio cyffuriau strwythur. Yn ogystal, gallai dealltwriaeth, ar lefel foleciwlaidd, o lwybrau signalau i lawr yr afon agor targedau newydd ar gyfer ymyrraeth therapiwtig.
Mae gen i ddiddordeb hefyd mewn defnyddio microsgopeg cryo-electron (cryoEM) i astudio strwythur 3D proteinau, ac yn ddiweddar rwyf wedi dechrau gweithio ar haemocyaninau molluscan; proteinau mawr, cymesur sy'n ddelfrydol ar gyfer datblygu'r dechneg hon.
Ar hyn o bryd mae'r gwaith yn fy labordy yn canolbwyntio ar bedair prif thema:
- Dylunio cyffuriau sy'n seiliedig ar strwythur gan ddefnyddio modelau moleciwlaidd o dderbynyddion P2X dynol
- Datblygu systemau gor-fynegiant ewcaryotig newydd ar gyfer derbynyddion P2X mamalaidd.
- Deall sail moleciwlaidd signalau i lawr yr afon yn dilyn actifadu derbynnydd P2X.
- CryoEM 3D-strwythur astudiaethau o haemocyanin molluscan
Rolau
Arweinydd academaidd, Hwb Ymchwil Technoleg Protein
Arwain, rhaglenni Ôl-raddedig Lefel 7 a Addysgir
Cydlynydd Cynllun Gradd Biocemeg
Arweinydd modiwlau, Biocemeg BI2232
Cynrychiolydd Caerdydd, Cyfleuster GW4 ar gyfer Cryo-microsgopeg Cydraniad Uchel
Cyhoeddiad
2024
- Coates, R. J., Scofield, S. and Young, M. T. 2024. Incorporation of regulatory DNA elements within a viral vector improves recombinant protein expression in plants. Scientific Reports 14(1), article number: 28865. (10.1038/s41598-024-80444-9)
- Smalley, C. J. H. et al. 2024. Understanding the solid-state structure of riboflavin through a multitechnique approach. Crystal Growth and Design 24(15), pp. 6256-6266. (10.1021/acs.cgd.4c00480)
2023
- Williamson, L. J. et al. 2023. Structure of the Lysinibacillus sphaericus Tpp49Aa1 pesticidal protein elucidated from natural crystals using MHz-SFX. Proceedings of the National Academy of Sciences 120(49), article number: e2203241120. (10.1073/pnas.2203241120)
- Pasqualetto, G. et al. 2023. CryoEM structure and Alphafold molecular modelling of a novel molluscan hemocyanin. PLoS ONE 18(6), article number: e0287294. (10.1371/journal.pone.0287294)
- Pasqualetto, G., Zuanon, M., Brancale, A. and Young, M. T. 2023. Identification of the molecular determinants of antagonist potency in the allosteric binding pocket of human P2X4. Frontiers in Pharmacology 14 (10.3389/fphar.2023.1101023)
- Pasqualetto, G., Zuanon, M., Brancale, A. and Young, M. T. 2023. Identification of a novel P2X7 antagonist using structure-based virtual screening. Frontiers in Pharmacology 13, article number: 1094607. (10.3389/fphar.2022.1094607)
2022
- Coates, R. J., Young, M. T. and Scofield, S. 2022. Optimising expression and extraction of recombinant proteins in plants. Frontiers in Plant Science 13, article number: 1074531. (10.3389/fpls.2022.1074531)
- Picarazzi, F. et al. 2022. Identification of small molecular chaperones binding p23h mutant opsin through an in silico structure-based approach. Journal of Chemical Information and Modeling 62(22), pp. 5794-5805. (10.1021/acs.jcim.2c01040)
- Smalley, C. et al. 2022. A structure determination protocol based on combined analysis of 3D-ED data, powder XRD data, solid-state NMR data and DFT-D calculations reveals the structure of a new polymorph of L-tyrosine. Chemical Science 13(18), pp. 5277-5288. (10.1039/D1SC06467C)
- Mender, M. M., Bolton, F., Berry, C. and Young, M. 2022. Antivenom: An immunotherapy for the treatment of snakebite envenoming in sub-Saharan Africa. In: Donev, R. ed. Immunotherapeutics., Vol. 129. Advances in Protein Chemistry and Structural Biology Elsevier, pp. 435-477., (10.1016/bs.apcsb.2021.11.004)
- Smalley, C. J. H., Logsdail, A. J., Hughes, C. E., Iuga, D., Young, M. T. and Harris, K. D. M. 2022. Solid-state structural properties of alloxazine determined from powder XRD data in conjunction with DFT-D calculations and solid-state NMR spectroscopy: unraveling the tautomeric identity and pathways for tautomeric interconversion. Crystal Growth and Design 22(1), pp. 524-534. (10.1021/acs.cgd.1c01114)
2020
- Grimes, L., Griffiths, J., Pasqualetto, G., Brancale, A., Kemp, P. J., Young, M. T. and van der Goes van Naters, W. 2020. Drosophila taste neurons as an agonist-screening platform for P2X receptors. Scientific Reports 10, article number: 8292. (10.1038/s41598-020-65169-9)
- Young, M. T. 2020. Journal club. Purinergic Signalling 16, pp. 257-259. (10.1007/s11302-020-09720-3)
- Young, M. T. 2020. Studying purinoceptor cell-surface expression by protein biotinylation. In: Pelegrin, P. ed. Purinergic Signaling: Methods and Protocols., Vol. 2041. Methods in Molecular Biology Springer, pp. 137-146., (10.1007/978-1-4939-9717-6_9)
2019
- Giancotti, G. et al. 2019. A new antiviral scaffold for human norovirus identified with computer-aided approaches on the viral polymerase. Scientific Reports 9(1), article number: 18413. (10.1038/s41598-019-54903-7)
- Pasqualetto, G. et al. 2019. Novel small-molecule chaperones to overcome opsin misfolding, mistrafficking and aggregation in retinal blinding diseases. Presented at: 2019 ARVO Annual Meeting, Vancouver, Canada, 28 April - 02 May 2019Investigative ophthalmology & visual science, Vol. 60. Vol. 9. ARVO
2018
- Pasqualetto, G., Brancale, A. and Young, M. T. 2018. The molecular determinants of small-molecule ligand binding at P2X receptors. Frontiers in Pharmacology 9, article number: 58. (10.3389/fphar.2018.00058)
2017
- Palma, L. et al. 2017. The Vip3Ag4 insecticidal protoxin from Bacillus thuringiensis adopts a tetrameric configuration that is maintained on proteolysis. Toxins 9(5), pp. 165. (10.3390/toxins9050165)
2015
- Grimes, L. and Young, M. 2015. Purinergic P2X receptors: Structural and functional features depicted by X-ray and molecular modelling studies. Current Medicinal Chemistry 22(7), pp. 783-798. (10.2174/0929867321999141212131457)
2014
- Fowler, B. J. et al. 2014. Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity. Science 346(6212), pp. 1000-1003. (10.1126/science.1261754)
2012
- Roberts, J. A., Allsopp, R. C., El Ajouz, S., Vial, C., Schmid, R., Young, M. T. and Evans, R. J. 2012. Agonist binding evokes extensive conformational changes in the extracellular domain of the ATP-gated human P2X1 receptor ion channel. Proceedings of the National Academy of Sciences 109(12), pp. 4663-4667. (10.1073/pnas.1201872109)
2011
- Valente, M., Watterson, S. J., Parker, M. D., Ford, R. C. and Young, M. T. 2011. Expression, purification, electron microscopy, N-glycosylation mutagenesis and molecular modeling of human P2X4 and Dictyostelium discoideum P2XA. Biochimica et Biophysica Acta (BBA) - Biomembranes 1808(12), pp. 2859-2866. (10.1016/j.bbamem.2011.08.025)
- Fujii, K., Young, M. T. and Harris, K. D. M. 2011. Exploiting powder X-ray diffraction for direct structure determination in structural biology: the P2X4 receptor trafficking motif YEQGL. Journal of Structural Biology 174(3), pp. 461-467. (10.1016/j.jsb.2011.03.001)
2010
- Wu, F. et al. 2010. Anion exchanger 1 interacts with nephrin in podocytes. Journal of the American Society of Nephrology 21(9), pp. 1456-1467. (10.1681/ASN.2009090921)
- Young, M. T. 2010. P2X receptors: dawn of the post-structure era. Trends in Biochemical Sciences 35(2), pp. 83-90. (10.1016/j.tibs.2009.09.006)
2009
- Cao, L., Broomhead, H., Young, M. T. and North, R. A. 2009. Polar residues in the second transmembrane domain of the rat P2X2 receptor that affect spontaneous gating, unitary conductance, and rectification. Journal of Neuroscience 29(45), pp. 14257-14264. (10.1523/JNEUROSCI.4403-09.2009)
2008
- Young, M. T., Fisher, J., Fountain, S. J., Ford, R. C., North, R. and Khakh, B. S. 2008. Molecular shape, architecture, and size of P2X4 receptors determined using fluorescence resonance energy transfer and electron microscopy. Journal of Biological Chemistry 283(38), pp. 26241-26251. (10.1074/jbc.M804458200)
- Fountain, S. J., Cao, L., Young, M. T. and North, R. 2008. Permeation properties of a P2X receptor in the green algae Ostreococcus tauri. Journal of Biological Chemistry 283(22), pp. 15122-15126. (10.1074/jbc.M801512200)
- Young, M. T., Zhang, Y., Cao, L., Broomhead, H. and Jiang, L. 2008. Role of the domain encompassing Arg304–Ile328 in rat P2X2 receptor conformation revealed by alterations in complex glycosylation at Asn298. Biochemical Journal 416(1), pp. 137-143. (10.1042/BJ20081182)
2007
- Cao, L., Young, M. T., Broomhead, H. E., Fountain, S. J. and North, R. A. 2007. Thr(339)-to-serine substitution in rat P2X(2) receptor second transmembrane domain causes constitutive opening and indicates a gating role for Lys(308). Journal of Neuroscience 27(47), pp. 12916-12923. (10.1523/JNEUROSCI.4036-07.2007)
- Fountain, S. J., Parkinson, K., Young, M. T., Cao, L., Thompson, C. R. L. and North, R. A. 2007. An intracellular P2X receptor required for osmoregulation in Dictyostelium discoideum. Nature 448(7150), pp. 200-203. (10.1038/nature05926)
- Barth, K., Weinhold, K., Guenther, A., Young, M. T., Schnittler, H. and Kasper, M. 2007. Caveolin-1 influences P2X(7) receptor expression and localization in mouse lung alveolar epithelial cells. Febs Journal 274(12), pp. 3021-3033. (10.1111/j.1742-4658.2007.05830.x)
- Parker, M. D., Young, M. T., Daly, C. M., Meech, R. W., Boron, W. F. and Tanner, M. J. A. 2007. A conductive pathway generated from fragments of the human red cell anion exchanger AE1. The Journal of Physiology 581(1), pp. 33-50. (10.1113/jphysiol.2007.128389)
- Lopez-Castejon, G., Young, M. T., Meseguer, J., Surprenant, A. and Mulero, V. 2007. Characterization of ATP-gated P2X(7) receptors in fish provides new insights into the mechanism of release of the leaderless cytokine interleukin-1 beta. Molecular Immunology 44(6), pp. 1286-1299. (10.1016/j.molimm.2006.05.015)
- Young, M. T., Pelegrin, P. and Surprenant, A. 2007. Amino acid residues in the P2X7 receptor that mediate differential sensitivity to ATP and BzATP. Molecular Pharmacology 71(1), pp. 92-100. (10.1124/mol.106.030163)
2006
- Young, M. T., Pelegrin, P. and Surprenant, A. 2006. Identification of Thr(283) as a key determinant of P2X(7) receptor function. British Journal of Pharmacology 149(3), pp. 261-268. (10.1038/sj.bjp.0706880)
- Sim, J. A. et al. 2006. Altered hippocampal synaptic potentiation in P2X(4) knock-out mice. Journal of Neuroscience 26(35), pp. 9006-9009. (10.1523/JNEUROSCI.2370-06.2006)
2005
- Mackenzie, A. B., Young, M. T., Adinolfi, E. and Surprenant, A. 2005. Pseudoapoptosis induced by brief activation of ATP-gated P2X7 receptors. Journal of Biological Chemistry 280(40), pp. 33968-33976. (10.1074/jbc.M502705200)
- Toye, A. M. et al. 2005. Protein-4.2 association with band 3 (AE1, SLCA4) in Xenopus oocytes: effects of three natural protein-4.2 mutations associated with hemolytic anemia. Blood 105(10), pp. 4088-4095. (10.1182/blood-2004-05-1895)
2004
- Sim, J. A., Young, M. T., Sung, H. Y., North, R. A. and Surprenant, A. 2004. Reanalysis of P2X(7) receptor expression in rodent brain. Journal of Neuroscience 24(28), pp. 6307-6314. (10.1523/JNEUROSCI.1469-04.2004)
2003
- Adinolfi, E., Kim, M., Young, M. T., Di Virgilio, F. and Surprenant, A. 2003. Tyrosine phosphorylation of HSP90 within the P2X(7) receptor complex negatively regulates P2X(7) receptors. Journal of Biological Chemistry 278(39), pp. 37344-37351. (10.1074/jbc.M301508200)
- Young, M. and Tanner, M. J. A. 2003. Distinct regions of human glycophorin A enhance human red cell anion exchanger (Band 3; AE1) transport function and surface trafficking. Journal of Biological Chemistry 278(35), pp. 32954-32961. (10.1074/jbc.M302527200)
- Kanki, T., Young, M. T., Sakaguchi, M., Hamasaki, N. and Tanner, M. J. A. 2003. The N-terminal region of the transmembrane domain of human erythrocyte band 3. Residues critical for membrane insertion and transport activity. Journal of Biological Chemistry 278(8), pp. 5564-5573. (10.1074/jbc.M211662200)
2000
- Young, M. T., Beckmann, R., Toye, A. M. and Tanner, M. J. A. 2000. Red-cell glycophorin A-band 3 interactions associated with the movement of band 3 to the cell surface. Biochemical Journal 350, pp. 53-60. (10.1042/0264-6021:3500053)
- Bruce, L. J. et al. 2000. Band 3 mutations, renal tubular acidosis and South-East Asian ovalocytosis in Malaysia and Papua New Guinea: loss of up to 95% band 3 transport in red cells. Biochemical Journal 350(1), pp. 41-51.
1998
- Dempsey, C. E., Sessions, R. B., Halsall, A., Takei, J., Gibbs, N. and Young, M. T. 1998. Helical structure and dynamics in membrane polypeptides. Biochemical Society Transactions 26(3), pp. 444-450. (10.1042/bst0260444)
Articles
- Coates, R. J., Scofield, S. and Young, M. T. 2024. Incorporation of regulatory DNA elements within a viral vector improves recombinant protein expression in plants. Scientific Reports 14(1), article number: 28865. (10.1038/s41598-024-80444-9)
- Smalley, C. J. H. et al. 2024. Understanding the solid-state structure of riboflavin through a multitechnique approach. Crystal Growth and Design 24(15), pp. 6256-6266. (10.1021/acs.cgd.4c00480)
- Williamson, L. J. et al. 2023. Structure of the Lysinibacillus sphaericus Tpp49Aa1 pesticidal protein elucidated from natural crystals using MHz-SFX. Proceedings of the National Academy of Sciences 120(49), article number: e2203241120. (10.1073/pnas.2203241120)
- Pasqualetto, G. et al. 2023. CryoEM structure and Alphafold molecular modelling of a novel molluscan hemocyanin. PLoS ONE 18(6), article number: e0287294. (10.1371/journal.pone.0287294)
- Pasqualetto, G., Zuanon, M., Brancale, A. and Young, M. T. 2023. Identification of the molecular determinants of antagonist potency in the allosteric binding pocket of human P2X4. Frontiers in Pharmacology 14 (10.3389/fphar.2023.1101023)
- Pasqualetto, G., Zuanon, M., Brancale, A. and Young, M. T. 2023. Identification of a novel P2X7 antagonist using structure-based virtual screening. Frontiers in Pharmacology 13, article number: 1094607. (10.3389/fphar.2022.1094607)
- Coates, R. J., Young, M. T. and Scofield, S. 2022. Optimising expression and extraction of recombinant proteins in plants. Frontiers in Plant Science 13, article number: 1074531. (10.3389/fpls.2022.1074531)
- Picarazzi, F. et al. 2022. Identification of small molecular chaperones binding p23h mutant opsin through an in silico structure-based approach. Journal of Chemical Information and Modeling 62(22), pp. 5794-5805. (10.1021/acs.jcim.2c01040)
- Smalley, C. et al. 2022. A structure determination protocol based on combined analysis of 3D-ED data, powder XRD data, solid-state NMR data and DFT-D calculations reveals the structure of a new polymorph of L-tyrosine. Chemical Science 13(18), pp. 5277-5288. (10.1039/D1SC06467C)
- Smalley, C. J. H., Logsdail, A. J., Hughes, C. E., Iuga, D., Young, M. T. and Harris, K. D. M. 2022. Solid-state structural properties of alloxazine determined from powder XRD data in conjunction with DFT-D calculations and solid-state NMR spectroscopy: unraveling the tautomeric identity and pathways for tautomeric interconversion. Crystal Growth and Design 22(1), pp. 524-534. (10.1021/acs.cgd.1c01114)
- Grimes, L., Griffiths, J., Pasqualetto, G., Brancale, A., Kemp, P. J., Young, M. T. and van der Goes van Naters, W. 2020. Drosophila taste neurons as an agonist-screening platform for P2X receptors. Scientific Reports 10, article number: 8292. (10.1038/s41598-020-65169-9)
- Young, M. T. 2020. Journal club. Purinergic Signalling 16, pp. 257-259. (10.1007/s11302-020-09720-3)
- Giancotti, G. et al. 2019. A new antiviral scaffold for human norovirus identified with computer-aided approaches on the viral polymerase. Scientific Reports 9(1), article number: 18413. (10.1038/s41598-019-54903-7)
- Pasqualetto, G., Brancale, A. and Young, M. T. 2018. The molecular determinants of small-molecule ligand binding at P2X receptors. Frontiers in Pharmacology 9, article number: 58. (10.3389/fphar.2018.00058)
- Palma, L. et al. 2017. The Vip3Ag4 insecticidal protoxin from Bacillus thuringiensis adopts a tetrameric configuration that is maintained on proteolysis. Toxins 9(5), pp. 165. (10.3390/toxins9050165)
- Grimes, L. and Young, M. 2015. Purinergic P2X receptors: Structural and functional features depicted by X-ray and molecular modelling studies. Current Medicinal Chemistry 22(7), pp. 783-798. (10.2174/0929867321999141212131457)
- Fowler, B. J. et al. 2014. Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity. Science 346(6212), pp. 1000-1003. (10.1126/science.1261754)
- Roberts, J. A., Allsopp, R. C., El Ajouz, S., Vial, C., Schmid, R., Young, M. T. and Evans, R. J. 2012. Agonist binding evokes extensive conformational changes in the extracellular domain of the ATP-gated human P2X1 receptor ion channel. Proceedings of the National Academy of Sciences 109(12), pp. 4663-4667. (10.1073/pnas.1201872109)
- Valente, M., Watterson, S. J., Parker, M. D., Ford, R. C. and Young, M. T. 2011. Expression, purification, electron microscopy, N-glycosylation mutagenesis and molecular modeling of human P2X4 and Dictyostelium discoideum P2XA. Biochimica et Biophysica Acta (BBA) - Biomembranes 1808(12), pp. 2859-2866. (10.1016/j.bbamem.2011.08.025)
- Fujii, K., Young, M. T. and Harris, K. D. M. 2011. Exploiting powder X-ray diffraction for direct structure determination in structural biology: the P2X4 receptor trafficking motif YEQGL. Journal of Structural Biology 174(3), pp. 461-467. (10.1016/j.jsb.2011.03.001)
- Wu, F. et al. 2010. Anion exchanger 1 interacts with nephrin in podocytes. Journal of the American Society of Nephrology 21(9), pp. 1456-1467. (10.1681/ASN.2009090921)
- Young, M. T. 2010. P2X receptors: dawn of the post-structure era. Trends in Biochemical Sciences 35(2), pp. 83-90. (10.1016/j.tibs.2009.09.006)
- Cao, L., Broomhead, H., Young, M. T. and North, R. A. 2009. Polar residues in the second transmembrane domain of the rat P2X2 receptor that affect spontaneous gating, unitary conductance, and rectification. Journal of Neuroscience 29(45), pp. 14257-14264. (10.1523/JNEUROSCI.4403-09.2009)
- Young, M. T., Fisher, J., Fountain, S. J., Ford, R. C., North, R. and Khakh, B. S. 2008. Molecular shape, architecture, and size of P2X4 receptors determined using fluorescence resonance energy transfer and electron microscopy. Journal of Biological Chemistry 283(38), pp. 26241-26251. (10.1074/jbc.M804458200)
- Fountain, S. J., Cao, L., Young, M. T. and North, R. 2008. Permeation properties of a P2X receptor in the green algae Ostreococcus tauri. Journal of Biological Chemistry 283(22), pp. 15122-15126. (10.1074/jbc.M801512200)
- Young, M. T., Zhang, Y., Cao, L., Broomhead, H. and Jiang, L. 2008. Role of the domain encompassing Arg304–Ile328 in rat P2X2 receptor conformation revealed by alterations in complex glycosylation at Asn298. Biochemical Journal 416(1), pp. 137-143. (10.1042/BJ20081182)
- Cao, L., Young, M. T., Broomhead, H. E., Fountain, S. J. and North, R. A. 2007. Thr(339)-to-serine substitution in rat P2X(2) receptor second transmembrane domain causes constitutive opening and indicates a gating role for Lys(308). Journal of Neuroscience 27(47), pp. 12916-12923. (10.1523/JNEUROSCI.4036-07.2007)
- Fountain, S. J., Parkinson, K., Young, M. T., Cao, L., Thompson, C. R. L. and North, R. A. 2007. An intracellular P2X receptor required for osmoregulation in Dictyostelium discoideum. Nature 448(7150), pp. 200-203. (10.1038/nature05926)
- Barth, K., Weinhold, K., Guenther, A., Young, M. T., Schnittler, H. and Kasper, M. 2007. Caveolin-1 influences P2X(7) receptor expression and localization in mouse lung alveolar epithelial cells. Febs Journal 274(12), pp. 3021-3033. (10.1111/j.1742-4658.2007.05830.x)
- Parker, M. D., Young, M. T., Daly, C. M., Meech, R. W., Boron, W. F. and Tanner, M. J. A. 2007. A conductive pathway generated from fragments of the human red cell anion exchanger AE1. The Journal of Physiology 581(1), pp. 33-50. (10.1113/jphysiol.2007.128389)
- Lopez-Castejon, G., Young, M. T., Meseguer, J., Surprenant, A. and Mulero, V. 2007. Characterization of ATP-gated P2X(7) receptors in fish provides new insights into the mechanism of release of the leaderless cytokine interleukin-1 beta. Molecular Immunology 44(6), pp. 1286-1299. (10.1016/j.molimm.2006.05.015)
- Young, M. T., Pelegrin, P. and Surprenant, A. 2007. Amino acid residues in the P2X7 receptor that mediate differential sensitivity to ATP and BzATP. Molecular Pharmacology 71(1), pp. 92-100. (10.1124/mol.106.030163)
- Young, M. T., Pelegrin, P. and Surprenant, A. 2006. Identification of Thr(283) as a key determinant of P2X(7) receptor function. British Journal of Pharmacology 149(3), pp. 261-268. (10.1038/sj.bjp.0706880)
- Sim, J. A. et al. 2006. Altered hippocampal synaptic potentiation in P2X(4) knock-out mice. Journal of Neuroscience 26(35), pp. 9006-9009. (10.1523/JNEUROSCI.2370-06.2006)
- Mackenzie, A. B., Young, M. T., Adinolfi, E. and Surprenant, A. 2005. Pseudoapoptosis induced by brief activation of ATP-gated P2X7 receptors. Journal of Biological Chemistry 280(40), pp. 33968-33976. (10.1074/jbc.M502705200)
- Toye, A. M. et al. 2005. Protein-4.2 association with band 3 (AE1, SLCA4) in Xenopus oocytes: effects of three natural protein-4.2 mutations associated with hemolytic anemia. Blood 105(10), pp. 4088-4095. (10.1182/blood-2004-05-1895)
- Sim, J. A., Young, M. T., Sung, H. Y., North, R. A. and Surprenant, A. 2004. Reanalysis of P2X(7) receptor expression in rodent brain. Journal of Neuroscience 24(28), pp. 6307-6314. (10.1523/JNEUROSCI.1469-04.2004)
- Adinolfi, E., Kim, M., Young, M. T., Di Virgilio, F. and Surprenant, A. 2003. Tyrosine phosphorylation of HSP90 within the P2X(7) receptor complex negatively regulates P2X(7) receptors. Journal of Biological Chemistry 278(39), pp. 37344-37351. (10.1074/jbc.M301508200)
- Young, M. and Tanner, M. J. A. 2003. Distinct regions of human glycophorin A enhance human red cell anion exchanger (Band 3; AE1) transport function and surface trafficking. Journal of Biological Chemistry 278(35), pp. 32954-32961. (10.1074/jbc.M302527200)
- Kanki, T., Young, M. T., Sakaguchi, M., Hamasaki, N. and Tanner, M. J. A. 2003. The N-terminal region of the transmembrane domain of human erythrocyte band 3. Residues critical for membrane insertion and transport activity. Journal of Biological Chemistry 278(8), pp. 5564-5573. (10.1074/jbc.M211662200)
- Young, M. T., Beckmann, R., Toye, A. M. and Tanner, M. J. A. 2000. Red-cell glycophorin A-band 3 interactions associated with the movement of band 3 to the cell surface. Biochemical Journal 350, pp. 53-60. (10.1042/0264-6021:3500053)
- Bruce, L. J. et al. 2000. Band 3 mutations, renal tubular acidosis and South-East Asian ovalocytosis in Malaysia and Papua New Guinea: loss of up to 95% band 3 transport in red cells. Biochemical Journal 350(1), pp. 41-51.
- Dempsey, C. E., Sessions, R. B., Halsall, A., Takei, J., Gibbs, N. and Young, M. T. 1998. Helical structure and dynamics in membrane polypeptides. Biochemical Society Transactions 26(3), pp. 444-450. (10.1042/bst0260444)
Book sections
- Mender, M. M., Bolton, F., Berry, C. and Young, M. 2022. Antivenom: An immunotherapy for the treatment of snakebite envenoming in sub-Saharan Africa. In: Donev, R. ed. Immunotherapeutics., Vol. 129. Advances in Protein Chemistry and Structural Biology Elsevier, pp. 435-477., (10.1016/bs.apcsb.2021.11.004)
- Young, M. T. 2020. Studying purinoceptor cell-surface expression by protein biotinylation. In: Pelegrin, P. ed. Purinergic Signaling: Methods and Protocols., Vol. 2041. Methods in Molecular Biology Springer, pp. 137-146., (10.1007/978-1-4939-9717-6_9)
Conferences
- Pasqualetto, G. et al. 2019. Novel small-molecule chaperones to overcome opsin misfolding, mistrafficking and aggregation in retinal blinding diseases. Presented at: 2019 ARVO Annual Meeting, Vancouver, Canada, 28 April - 02 May 2019Investigative ophthalmology & visual science, Vol. 60. Vol. 9. ARVO
Ymchwil
Cyflwyniad
Mae derbynyddion P2X yn sianeli ïon ATP-gratio sy'n chwarae rolau allweddol mewn amrywiaeth o brosesau ffisiolegol fel trosglwyddo synaptig, teimlad blas a rheolaeth cyhyrau llyfn. Maent yn gweithredu mewn celloedd fel trimers, gyda dau barth trawsbilen fesul monomer a pharthau allgellog glycosylated mawr, glycosylated [1]. Cyhoeddwyd sawl strwythur crisial o dderbynyddion P2X yn ddiweddar (gan gynnwys rhai pysgod sebra P2X4 yn y cyflwr apo- ac ATP [2]), gan drawsnewid ein dealltwriaeth o'u perthynas strwythur-swyddogaeth [3], ond mae angen mwy o strwythurau, yn enwedig o'r isdeipiau dynol, ac mae hyn yn her sylweddol oherwydd mae'n anodd mynegi a phuro proteinau bilen ewcaryotig yn y symiau mawr sy'n ofynnol ar gyfer astudiaeth strwythurol.
Mae derbynyddion P2X hefyd yn ymwneud â llid. Mynegir isdeip derbynnydd P2X7 mewn celloedd imiwnedd; ac yn y llygod cyw allan yn brin P2X7, diddymwyd poen llidiol cronig, tra bod ymatebion poen acíwt yn aros yn ddigyfnewid [4]. Mae P2X7 yn unigryw ymhlith derbynyddion P2X gan fod ei actifadu yn arwain at ryddhau cytocinau pro-llidiol, ac mae actifadu hir yn achosi marwolaeth celloedd [5]. Mae priodweddau P2X7 yn cael eu rheoleiddio gan ei barth C-derfynell fewngellog hir, sy'n cyplu actifadu sianel ïon i signalau i lawr yr afon, ac awgrymwyd yn ddiweddar y gallai targedu signalau i lawr yr afon P2X7 gyfryngu fod yn strategaeth dda i ddatblygu cyffuriau gwrthlidiol mwy dethol [6].
Nodau
Archwilio mynegiant derbynyddion P2X mewn systemau ewcaryotig eraill
Rydym wedi mynegi derbynyddion P2X yn llwyddiannus mewn celloedd pryfed sydd wedi'u heintio â baculofirws [7] (ar y cyd â Dr Mark Parker, Case Western, UDA). Defnyddiwyd mynegiant celloedd pryfed yn llwyddiannus wrth ddatrys strwythur pysgod sebra P2X4 [2], felly mae'n cynrychioli system brofedig ar gyfer mynegi derbynyddion P2X. Rydym yn datblygu'r pryf ffrwythau Drosophila melanogaster fel system mynegiant ar gyfer proteinau bilen sy'n caniatáu astudiaethau strwythurol a swyddogaethol (ar y cyd â Dr Wynand Van der Goes Van Naters, Ysgol y Biowyddorau). Yn ddiweddar rydym hefyd wedi datblygu cydweithrediad â Dr Simon Scofield (Ysgol y Biowyddorau) i ddatblygu systemau mynegiant planhigion ar gyfer derbynyddion P2X.
P2X7 llwybrau signalau i lawr yr afon
Ar ôl actifadu gan ATP allgellog, cyplau P2X7 trwy ei barth C-derfynell hir i sawl llwybr signalau mewngellol, gan arwain at recriwtio llid NRLP3 a rhyddhau cytocinau pro-llidiol [5]. Mae gan y signalau hyn ganlyniadau pwysig mewn poen a llid, yn enwedig mewn cyflyrau llid cronig fel arthritis, clefyd Alzheimer a dirywiad macwlaidd sy'n gysylltiedig ag oedran (AMD). Mewn cydweithrediad â'r Athro Jayakrishna Ambati (Prifysgol Virginia, UDA), roeddem yn gallu dangos bod tarfu ar signalau P2X7 gyda modulator moleciwl bach wedi diddymu marwolaeth celloedd epithelial pigment retinol a welir yn AMD, gan gynnig gobaith y gallai P2X7 fod yn darged ar gyfer y clefyd anwelladwy hwn [8]. Er bod llawer o gydrannau i lawr yr afon o'r llwybrau signalau wedi'u nodweddu, nid yw sail moleciwlaidd y cam cyntaf yn y broses hon yn hysbys o hyd. Pa broteinau mae'r parth P2X7 C-terminal yn rhyngweithio â nhw, a sut mae'r rhyngweithiadau hyn yn cael eu rheoleiddio?
Dylunio cyffuriau sy'n seiliedig ar strwythur gan ddefnyddio modelau moleciwlaidd o dderbynyddion P2X dynol
Er nad oes gennym strwythurau cydraniad uchel ar gyfer naill ai P2X4 dynol neu P2X7 dynol, rydym wedi adeiladu modelau moleciwlaidd yn seiliedig ar strwythur crisial ATP pysgod zebrafish P2X4 [2] a strwythur cryoEM o llygoden fawr P2X7 [9]. Mewn cydweithrediad â Dr Andrea Brancale (Ysgol Fferylliaeth) rydym wedi defnyddio'r modelau moleciwlaidd hyn i berfformio mewn docio silico o ystod o gyfansoddion tebyg i gyffuriau i safle rhwymo ATP, gan ddewis y rhai sy'n rhoi'r ffit orau ar gyfer profion swyddogaethol gan ddefnyddio cymeriant calsiwm ac electroffisioleg. Yn y modd hwn rydym yn gobeithio darganfod cyfansoddion 'daro' sy'n modiwleiddio swyddogaeth derbynnydd P2X, y gellir eu haddasu ymhellach wedyn i ddatblygu cyffuriau cryf a detholus, a allai fod o fudd therapiwtig sylweddol mewn cyflyrau poen a llid.
Technoleg protein
Fel rhan o'r Ganolfan Technoleg Protein, rwy'n gweithio gyda Mikota PLC i ddatblygu puro a phrofi'r gweithdrefnau ar gyfer haemocyanin limped llithrig a collagen. Mae limpedi llithrig yn rhywogaeth ymledol yn y DU sy'n dinistrio cynefinoedd morol; Byddai dod o hyd i ddefnydd masnachol ar eu cyfer yn cymell eu symud a chynorthwyo adferiad ecosystemau (http://www.cardiff.ac.uk/news/view/987729-life-saving-limpets). Rwyf hefyd yn cydweithio â'r Athro Kenneth Harris (Ysgol Cemeg) gan ddefnyddio diffreithiant pelydr-X powdr ar gyfer astudiaeth strwythurol moleciwlau sy'n berthnasol yn fiolegol.
- Grimes L and Young MT (2015) Derbynyddion P2X Purinergig: nodweddion strwythurol a swyddogaethol a ddarlunnir gan belydr-X ac astudiaethau modelu moleciwlaidd. Curr Med Chem 22, 783-98.
- Hattori M and Gouaux E (2012) Mecanwaith moleciwlaidd o ATP rhwymo ac actifadu sianel ïonau mewn derbynyddion P2X. Natur 485, 207-212
- Pasqualetto G et al. (2018) Mae'r penderfynyddion moleciwlaidd o ligand moleciwl-bach rhwymo ar dderbynyddion P2X. Ffiniau mewn Ffarmacoleg 9, 58.
- Chessell IP et al. (2005) Mae tarfu ar y genyn purinoceptor P2X7 yn cael gwared â phoen llidiol cronig a niwropathig. Poen 114, 386-396
- Sluyter R (2017) Derbynnydd P2X7. Adv Exp Med Biol. doi: 10.1007 / 5584_2017_59
- Mae Sorge RE et al. (2012) a benderfynir yn enetig P2X7 yn rheoleiddio amrywioldeb mewn sensitifrwydd poen cronig. Nat Med 18, 595-599
- Valente M et al. (2011) Mynegiant, puro, microsgopeg electron, mutagenesis N-glycosylation a modelu moleciwlaidd P2X4 dynol a Disgoideum Dictyostelium P2XA. Bioffioedd Acta 1808, 2859-2866
- Fowler BJ et al. (2014) Mae gan atalyddion trawsgrifiadau gwrthdroi niwcleosid weithgaredd gwrthlidiol cynhenid. Gwyddoniaeth 346, 1000-1003
- Mae strwythurau McCarthy AE et al. (2019) hyd llawn P2X7 yn datgelu sut mae Palmitoylation yn atal dadsensiteiddio sianel. Cell 2019 Hyd 17; 179(3): 659-670
Cydweithredwyr presennol
Prifysgol Caerdydd
Mikota PLC
- Alex Mühlhölzl
Myfyrwyr ymchwil ôl-raddedig
- Miss Marika Zuanon
- Mr Ryan Coates
Addysgu
I teach in the Biochemistry/Protein Engineering subject areas in Years 2, 3 and 4. Subject areas include quantitative biochemistry, protein structure determination, protein purification, protein detection, enzyme regulation, structure-based drug design, membrane protein structure and synthetic biology chassis organisms.
I offer research projects in Years 3 and 4 looking at the structure-function relationship of plasma membrane ion channels and their roles in heath and disease.
I also teach Biochemistry and Exercise Physiology in the Platform for Clinical Science (Medical School).
Bywgraffiad
Dechreuais ymddiddori mewn astudio cydberthnasau strwythur strwythur protein bilen yn ystod fy ngradd Biocemeg ym Mhrifysgol Bryste (1994-1997). Arhosais ymlaen ym Mryste ar gyfer fy Ph.D. a'r postdoc cyntaf (1997-2003) dan arweiniad yr Athro Mike Tanner, lle bues i'n archwilio'r rhyngweithio rhwng cludwr anion celloedd gwaed coch (band 3) a'i is-uned affeithiwr, Glycophorin A (GPA)
Arweiniodd diddordeb cynyddol mewn sianeli ïonau i mi ymgymryd â postdocs gydag Athrawon. Annmarie Surprenant ac Alan North ym Mhrifysgolion Sheffield (2003-2005) a Manceinion (2005-2007), lle gweithiais ar gysylltiadau strwythur derbynnydd P2X. Yn ystod y cyfnod hwn, symudodd ffocws fy ymchwil tuag at astudiaeth strwythurol uniongyrchol derbynyddion P2X. Gyda chymorth Cymrodoriaeth Hyfforddiant Uwch (2007-2010) a mentoriaeth yr Athro Bob Ford (Prifysgol Manceinion), penderfynais strwythur P2X4 dynol ar gydraniad o 21å, gan ddefnyddio microsgopeg electron o ronynnau protein sengl ac ailadeiladu 3D.
Ym mis Medi 2009 dechreuais Gymrodoriaeth Evans-Huber ym Mhrifysgol Caerdydd, sydd wedi fy ngalluogi i sefydlu fy labordy ymchwil fy hun, lle rwy'n parhau i astudio strwythur 3D a swyddogaethau signalau i lawr yr afon derbynyddion P2X mamalaidd, yn ogystal â cheisio datblygu systemau mynegiant newydd ar gyfer proteinau pilen mamalaidd. Deuthum yn Ddarlithydd (Addysgu ac Ymchwil) ym mis Medi 2012. Cefais fy nyrchafu yn Uwch-ddarlithydd yn 2015, a deuthum yn Arweinydd Academaidd y Ganolfan Ymchwil Technoleg Protein newydd yn 2016. Yn 2021 cefais fy nyrchafu i Ddarllenydd.
Yn fwyaf diweddar, rwyf wedi dod â diddordeb mewn sut mae moleciwlau bach yn rhwymo i dderbynyddion P2X i fodiwleiddio eu swyddogaeth, a defnyddio micsorgopi cryo-electron (cryoEM) i astudio strwythur 3D proteinau.
Meysydd goruchwyliaeth
Prosiect PhD ar gael:
Sut mae activation derbynnydd P2X7 yn cyfateb i signalau i lawr yr afon?
Mae derbynyddion P2X7 yn sianeli ïonau a geir ar wyneb celloedd imiwnedd, lle maent yn ymateb i rwymo ATP allgellog, signal difrod a ryddhawyd gan gelloedd sy'n marw mewn haint ac anaf. Mae rhwymo ATP i dderbynyddion P2X7 yn arwain at fewnlifiad calsiwm ac yn cychwyn rhaeadr signalau i lawr yr afon, gan arwain at ffurfio pores fawr yn y bilen plasma, newidiadau mewn siâp celloedd, secretiad protein, actifadu kinase a newidiadau mewn mynegiant genynnau. Mae swyddogaeth sianel ïon a signalau i lawr yr afon yn cael eu rheoleiddio'n uchel gan barthau mewngellol C-terminal 30 amino-asid a 240 amino-asid C-terminal y derbynnydd (NTD a CTD), yn rhannol o leiaf trwy ryngweithio â lipidau yn y bilen plasma, ond ychydig iawn a wyddom am eu rhyngweithio â biomoleciwlau eraill, neu pa rannau ohonynt sy'n ymwneud â llwybrau signalau. Mae cyhoeddiad diweddar strwythur cryoEM o rat hyd llawn P2X7 yn dangos bod y NTD a'r gyfran N-derfynell gyfoethog cystein o'r CTD (angor C-Cys) wedi'u palmitoylated, gan angori'r parthau hyn i daflen fewnol y bilen plasma, a bod cyfran C-derfynell y CTD (balast) yn ffurfio parth globular sy'n cynnwys safleoedd rhwymo ar gyfer sinc diniwclear a CMC / GTP, codi cwestiynau diddorol am ei swyddogaeth bosibl.
Ffocws y prosiect hwn fydd deall rôl parthau mewngellol P2X7 mewn signalau i lawr yr afon, gan ddefnyddio cyfuniad o fodelu moleciwlaidd, mutagenesis a gyfeiriwyd ar y safle, mynegiant protein, puro protein a phrofion swyddogaethol. Rhoddir ffocws penodol ar ddeall rôl lipidau wrth reoleiddio swyddogaeth derbynyddion, a rôl y parth balast wrth gyplysu rhaeadrau signalau mewngellog. Byddwn hefyd yn ceisio mynegi a phuro derbynyddion P2X7 hyd llawn (neu eu parthau mewngellol) ar gyfer astudiaeth strwythur 3D gan ddefnyddio crisialograffeg cryoEM neu belydr-X.
Contact Details
+44 29208 79394
Adeilad Syr Martin Evans, Ystafell W/2.48, Rhodfa'r Amgueddfa, Caerdydd, CF10 3AX
Themâu ymchwil
Arbenigeddau
- Bioleg strwythurol
- Derbynyddion a bioleg pilen
- Datblygu cyffuriau